Old Web
English
Sign In
Acemap
>
authorDetail
>
Matthew Bridgland-Taylor
Matthew Bridgland-Taylor
Safety Pharmacology Society
Pharmacology
Medicine
Internal medicine
Cardiology
hERG
4
Papers
42
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Prediction and Modeling of Effects on the QTc Interval for Clinical Safety Margin Assessment, Based on Single-Ascending-Dose Study Data with AZD3839
2014
Journal of Pharmacology and Experimental Therapeutics
Erik Sparve
Angelica Quartino
Maria Lüttgen
Karin Tunblad
Anna Teiling-Gårdlund
Johanna Fälting
Robert Alexander
Jens Kågström
Linnea Sjödin
Alexander Bulgak
Ahmad Al-Saffar
Matthew Bridgland-Taylor
Chris Pollard
Michael D.B. Swedberg
Torbjorn Vik
Björn Paulsson
Show All
Source
Cite
Save
Citations (13)
Validation of a voltage-sensitive dye (di-4-ANEPPS)-based method for assessing drug-induced delayed repolarisation in Beagle dog left ventricular midmyocardial myocytes
2009
Journal of Pharmacological and Toxicological Methods
Matthew E.L. Hardy
Chris Pollard
Ben G. Small
Matthew Bridgland-Taylor
Ann J. Woods
Jean-Pierre Valentin
Najah Abi-Gerges
Show All
Source
Cite
Save
Citations (24)
Characterisation of an activator of the hERG-encoded potassium channel
2008
Journal of Pharmacological and Toxicological Methods
Matthew Bridgland-Taylor
H. Pye
R. Mannikko
N. Abi Gerges
Alison Easter
J.-P. Valentin
C.E. Pollard
Show All
Source
Cite
Save
Citations (1)
Characterisation of an ionworks-based assay for the hKCNQ1/hKCNE1 (IKs) cardiac ion channel
2008
Journal of Pharmacological and Toxicological Methods
Matthew Bridgland-Taylor
C.M. Gorvin
J.M. Ellston
J.-P. Valentin
M. Main
C.E. Pollard
Show All
Source
Cite
Save
Citations (4)
1